Cost-Effectiveness

Tuesday, June 14, 2016: 1:15 PM-2:45 PM
419 (Fisher-Bennett Hall)
Chair:
Dr. David Meltzer

z

1:15 PM
Cost-eff ectiveness of high-dose versus standard-dose inactivated infl uenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial

Author(s): Ayman Chit

Discussant:

1:35 PM
COST-UTILITY ANALYSIS OF A NOVEL PHARMACIST-GUIDED WARFARIN PHARMACOGENETIC SERVICE IN 1 TO 5 YEAR TIME HORIZONS

Author(s): Surrey M Walton; Kibum Kim

Discussant:

1:55 PM
Incremental Costs of Rheumatoid Arthritis Treatment: A National Population-Based Study 2002-2013

Author(s): Elham Mahmoudi

Discussant: Prof. Allen Goodman
See more of: Costs and Benefits of Specific Medical Treatments
<< Previous Session | Next Session >>

American Society of Health Economists (ASHEcon)

1100 Vermont Avenue NW Suite 650

Washington, DC 20005

P: (202) 737 6608

F: (202) 496 0134

Copyright © 2017 ASHEcon - All rights reserved.